The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Promising role of liquid biopsies in lung cancer
Adam Januszewski, from St Bartholomew’s Hospital in London, discusses the promising role of liquid biopsies in lung cancer patients. He highlights their use in identifying new mutations and expediting treatment initiation, ultimately benefiting patients. Dr Januszewski emphasizes the significance of liquid biopsies in enhancing the genomic literacy of multidisciplinary teams and anticipates their integral role in the future pathway of lung cancer management. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
